Opinion

Video

Overview of Molecular Testing and Barriers in mCRC

The panel of CRC experts explores the significance of molecular testing for mCRC patients, emphasizing recommended biomarkers and optimal testing timelines.

  1. Dr Marshall to Dr Cohen: How would you describe the role of molecular testing for patients with mCRC?
    1. Which biomarkers are recommended for testing and when are patients tested?
  2. Dr Marshall to Panel: Briefly describe commonly used testing strategies of molecular markers for patients with mCRC.
    1. Is there a continued role for ctDNA in molecular testing for patients with mCRC?
    2. Dr Benson: What are some barriers to molecular testing in practice?

Related Videos
Jonathan C. Trent, MD, PhD
5 KOLs are featured in this panel.
5 KOLs are featured in this panel.
2 KOLs are featured in this panel.
2 KOLs are featured in this panel.
Video 6 - 2 KOLs are featured in, "Other trials of note investigating targeted therapies in later line HR+/HER2- mBC"
Video 5 - 2 KOLs are featured in, "Targeted Therapies in HR+/HER2- mBC: CAPItello-291"
4 KOLs are featured in this series
4 KOLs are featured in this series
2 KOLs are featured in this program.